Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy (FLEET): A Randomized Controlled Trial

NCT07619092 is registered in ClinicalTrials.gov with Anders Jørgensen as lead sponsor.

NCT NCT07619092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07619092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy (FLEET): A Randomized Controlled Trial
Lead sponsor
Anders Jørgensen
Phase
Not applicable
Overall status
Recruiting
Start date
January 15, 2026
Completion date
August 31, 2028
Enrollment
145 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autobiographical memory, bipolar disorder (bd), cognition, depression - major depressive disorder, ect, electroconvulsive therapy, functional magnetic resonance imaging (fmri), inpatients, treatment outcome